Significant contributions have been made by technological improvements in radiotherapy ... here will be applied to head and neck cancer, in which the impact of concurrent chemoradiotherapy ...
For patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC) with a contraindication for cis ...
Optimal treatment for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) unfit for cisplatin ...
Head and neck cancers are the seventh most common ... are disproportionately affected. The chemotherapy drug cisplatin, when ...
Head and neck cancers are the seventh most common ... are disproportionately affected. The chemotherapy drug cisplatin, when ...
Statin use during concurrent chemoradiotherapy ... including the ability to enhance chemotherapy efficacy and reduce radiotherapy toxicity. The integration of statins with standard CCRT regimens ...